DARYL SHORTER

Concepts (82)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
8
2020
202
2.700
Why?
Receptors, Adrenergic, alpha-1
3
2020
17
1.640
Why?
Doxazosin
3
2020
28
1.240
Why?
Substance-Related Disorders
5
2018
458
1.200
Why?
Adrenergic alpha-1 Receptor Antagonists
3
2020
18
0.740
Why?
Psychiatry
2
2015
263
0.680
Why?
Addiction Medicine
1
2018
3
0.610
Why?
Self-Assessment
1
2018
66
0.590
Why?
Adolescent Behavior
1
2018
171
0.530
Why?
Disulfiram
2
2013
34
0.520
Why?
Cocaine
2
2016
206
0.500
Why?
Alcohol Deterrents
2
2019
12
0.480
Why?
Needs Assessment
1
2015
176
0.440
Why?
Drug Design
1
2014
146
0.440
Why?
Internship and Residency
2
2015
1170
0.420
Why?
Curriculum
1
2018
723
0.410
Why?
Molecular Targeted Therapy
1
2014
353
0.400
Why?
Drug Therapy, Combination
1
2015
1154
0.390
Why?
Opioid-Related Disorders
4
2016
261
0.390
Why?
Double-Blind Method
6
2020
1614
0.380
Why?
Narcotic Antagonists
3
2016
107
0.360
Why?
Buprenorphine
3
2016
95
0.350
Why?
Data Collection
1
2012
384
0.340
Why?
Polymorphism, Genetic
3
2020
807
0.340
Why?
Stress Disorders, Post-Traumatic
2
2019
629
0.330
Why?
Pilot Projects
3
2020
1396
0.310
Why?
Genotype
4
2020
2548
0.290
Why?
Polymorphism, Single Nucleotide
1
2016
2604
0.290
Why?
Pharmacogenetics
2
2020
183
0.270
Why?
GABA Agents
2
2019
21
0.260
Why?
Dopamine beta-Hydroxylase
2
2018
29
0.250
Why?
Opiate Substitution Treatment
2
2016
25
0.240
Why?
Clinical Trials as Topic
3
2017
1086
0.180
Why?
Vaccines
2
2017
369
0.180
Why?
Humans
17
2020
124270
0.160
Why?
Combined Modality Therapy
2
2020
1244
0.160
Why?
Valproic Acid
1
2019
164
0.150
Why?
Adult
6
2020
29357
0.140
Why?
Alcoholism
1
2019
230
0.140
Why?
Methadone
2
2016
124
0.140
Why?
Female
8
2020
66294
0.130
Why?
Adrenergic alpha-2 Receptor Agonists
1
2016
24
0.130
Why?
Pharmacogenomic Variants
1
2016
35
0.130
Why?
Legislation, Medical
1
2016
13
0.130
Why?
Drug Discovery
1
2017
170
0.130
Why?
Middle Aged
6
2020
26367
0.130
Why?
Diagnosis, Dual (Psychiatry)
1
2015
20
0.130
Why?
Male
8
2020
60887
0.130
Why?
Administration, Intravenous
1
2016
143
0.130
Why?
Educational Measurement
1
2018
324
0.120
Why?
Amino Acid Substitution
1
2016
393
0.120
Why?
Drug Prescriptions
1
2016
220
0.110
Why?
Brain Injuries, Traumatic
1
2019
374
0.110
Why?
Health Care Surveys
1
2015
286
0.110
Why?
Prescription Drugs
1
2014
53
0.110
Why?
Forecasting
1
2015
353
0.110
Why?
Education, Medical, Graduate
1
2018
511
0.110
Why?
United States
4
2019
10756
0.100
Why?
Treatment Outcome
5
2018
12264
0.100
Why?
Berberine Alkaloids
1
2011
2
0.100
Why?
Dopamine Agonists
1
2011
79
0.090
Why?
Research Design
1
2014
688
0.090
Why?
Analgesics, Opioid
1
2014
408
0.090
Why?
Vaccination
2
2014
953
0.080
Why?
Global Health
1
2014
555
0.080
Why?
Immunotherapy
1
2014
663
0.080
Why?
Alleles
1
2013
1611
0.080
Why?
Naltrexone
2
2019
69
0.070
Why?
Veterans
1
2019
1750
0.070
Why?
Cross-Sectional Studies
1
2015
3412
0.070
Why?
Young Adult
2
2016
8954
0.060
Why?
Brain
1
2015
3000
0.060
Why?
Adolescent
2
2018
19308
0.050
Why?
Norepinephrine
1
2018
174
0.040
Why?
Drug Evaluation, Preclinical
1
2017
152
0.040
Why?
Clonidine
1
2016
35
0.030
Why?
Recurrence
1
2019
1423
0.030
Why?
Aged
1
2013
19386
0.030
Why?
Comorbidity
1
2019
1506
0.030
Why?
Animals
1
2014
34158
0.030
Why?
Safety
1
2014
218
0.030
Why?
Antibodies
1
2014
372
0.030
Why?
SHORTER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_